|RBC Capital Markets||Douglas Miehm|
|Canaccord Genuity||Neil Maruoka|
|Echelon Wealth Partners||Douglas Loe|
|Paradigm Capital||Rahul Sarugaser|
Oncolytics Biotech, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Oncolytics Biotech, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Oncolytics Biotech, Inc. or its management. Oncolytics Biotech, Inc. does not by its reference above or distribution, imply its endorsement of or concurrence with such information, conclusions or recommendations.